ν€νλ¦° (λ―ΈλΆν)
ν€νλ¦°μ μμνμμ νμ μμ μ± μ§νμ μλ°© λ° μΉλ£νκ³ μ λ§₯ μΉ΄ν ν°μ κ°ν΅μ±μ μ μ§νλ λ° μ¬μ©λλ λ―ΈλΆν μ£Όμ¬μ© νμκ³ μ μ λλ€. ν¨κ³Όλ₯Ό λ°ννκΈ° μν΄ λ΄μΈμ± ννΈλ‘¬λΉ III(AT III)μ μ‘΄μ¬μ μμ‘΄ν©λλ€. > **μμ κ²½κ³ :** ν€νλ¦°μ μΆνμ μ¬κ°ν μνμ μλ°ν©λλ€. κΈ°μ‘΄μ νμ μ μ©ν΄νμ§λ μμ§λ§ νμ₯μ λ°©μ§ν©λλ€. **μμ ν:** ν€νλ¦°μ΄ κΈ°λ₯νλ €λ©΄ AT IIIκ° νμνλ―λ‘, μ¬κ°ν λ¨λ°±μμ€μ± μ μ¦μ΄λ μ₯λ³μ¦μΌλ‘ μΈν΄ AT IIIκ° κ³ κ°λ νμμκ²λ ν¨κ³Όκ° μμ μ μμ΅λλ€.
μμ© κΈ°μ : Heparin exerts its effects primarily by enhancing the binding of **antithrombin III (AT III)** to **factors IIa, IXa, Xa, XIa and XlIa**. * **AT III/clotting factor complex** formation β subsequent removal by the liver. * Inactivates **thrombin** β blocks the conversion of **fibrinogen** to **fibrin**. * Inhibition of **Factor XII** activation β prevents the formation of stable fibrin clots. > **Note:** Heparin is only effective if adequate AT III is present. It does not significantly change the concentrations of clotting factors, nor does it lyse pre-existing clots.
ν¬μ¬ κ²½λ‘
κΈκΈ°
- Active bleeding or severe bleeding disorders
- Severe thrombocytopenia
- Recent neurosurgery or ocular surgery
- Known hypersensitivity to heparin
μ΄μλ°μ
- Hemorrhage (most common)
- Heparin-induced thrombocytopenia (HIT)
- Injection site reactions (hematoma, pain)
- Hypersensitivity reactions
μ½λ¬Ό μνΈμμ©
- Aspirin Β· Increased risk of bleeding due to platelet inhibition Β· major
- NSAIDs Β· Increased risk of gastrointestinal ulceration and bleeding Β· major
- Warfarin Β· Synergistic anticoagulant effect; increased bleeding risk Β· major
- Clopidogrel Β· Increased risk of bleeding Β· major
λͺ¨λν°λ§
- aPTT (Activated Partial Thromboplastin Time) - typically target 1.5 to 2.5 times baseline
- Platelet count
- Packed Cell Volume (PCV) and Total Protein (TP)
- Clinical signs of bleeding (mucous membranes, feces, urine)
κ³Όμ©λ
The primary sign of overdosage is **hemorrhage** (e.g., epistaxis, hematuria, melena, petechiae). * **Mild to moderate overdose:** Discontinue heparin therapy; due to its short half-life, coagulation parameters often normalize quickly. * **Severe, life-threatening hemorrhage:** Administer **protamine sulfate** as a specific reversal agent (antidote). Administer slowly IV to avoid hypotension and anaphylactoid reactions.
VetSheet μ½λ¬Ό λ νΌλ°μ€λ λ©΄ν μμ μ λ¬Έκ°λ₯Ό μν μμ μμ¬κ²°μ 보쑰 λꡬμ΄λ©°, μ λ¬Έμ νλ¨μ΄λ μ μ‘°μ¬μ μ΅μ λΌλ²¨μ λμ νμ§ μμ΅λλ€.